Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma

CompletedOBSERVATIONAL
Enrollment

97

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Lymphoma, Non-Hodgkin
Interventions
OTHER

Ribomustin

Routine practice

OTHER

rituximab

Routine practice

Trial Locations (35)

105203

Scientific Medical Surgical Center n.a.I.V.Pyrogov/17, Moscow

105229

European Medical Center, Moscow

115478

RONC n.a.N.N.Blokhin/18, Moscow

129128

Сentral Clinical Hospital n.a. Semashko N.A./30, Moscow

160002

Vologda Regional Clinical Hospital/39, Vologda

197022

City Сlinical Oncological Dispensary/22, Saint Petersburg

197110

City Сlinical Hospital#31/08, Saint Petersburg

197758

Military-Medical Academy n.a. Kirova, Saint Petersburg

Scientific Research Oncological Institution n.a. Petrov N.N./29, Saint Petersburg

214025

Road Clinical Hospital on Rostov-Main Station OAO RZhD/06, Smolensk

248007

Kaluga Regional Clinical Hospital/02, Kaluga

249036

Medical Radiology Scientific Center/38, Obninsk

300053

Tula Regional Clinical Hospital/21, Tula

344037

Rostov Scientific Research Oncology Institution/01, Rostov-on-Don

385017

Adygei Regional Clinical Oncology Dispensary/11, Maykop

400138

Volgograd Regional Clinical Oncology Dispensary#1/10, Volgograd

443099

Moscow Scientific Research Oncology Institution n.a.P.A. Gertzen/37, Moscow

Samara State Medical University' Clinics/36, Samara

454087

Chelyabinsk Regional Oncology Dispensary/15, Chelyabinsk

460000

Orenburg State Medical Academy/05, Orenburg

603003

Municipal Сlinical Hospital № 12/20, Nizhny Novgorod

630087

Novosibirsk State Regional Clinical Hospital/23, Novosibirsk

644111

Omsk Regional Clinical Hospital/40, Omsk

644112

City Сlinical Hospital#1 n.a.Kabanov A.N./13, Omsk

660003

City Сlinical Hospital#7/25, Krasnoyarsk

660022

Regional Сlinical Hospital/12, Krasnoyarsk

664035

Regional Oncology Dispensary/35, Irkutsk

664079

Irkutsk Regional Сlinical Hospital/31, Irkutsk

693010

Sakhalin Regional Oncology Dispensary/32, Yuzhno-Sakhalinsk

Unknown

City Clinical Hospital #8, Barnaul

Vologda Regional Clinical Hospital #2, Cherepovets

District Cancer center od Khanty -Mansiysk, Khanty-Mansiysk

Central Clinical Hospital of Department of Presidential Affairs, Moscow

Surgut Regional Clinical Hospital, Surgut

Yekaterinburg Regional Clinical Hospital #1, Yekaterinburg

All Listed Sponsors
lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT02072967 - Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter